Long COVID-19 a Priority for Biden Administration, Drug Developers

August 10th 2022

A rise in the number of long COVID is sparking research efforts by the HHS, the CDC and drug companies to understand the conditions and develop treatments.

FDA Extends Review of Omaveloxolone in Friedreich’s Ataxia

August 10th 2022

The updated PDUFA date is Feb. 28, 2023, and the planned advisory committee meeting is on hold pending review of NDA amendments.

FDA Approves Myfembree to Treat Endometriosis

August 9th 2022

The approval had been delayed as the regulatory agency reviewed data on Myfembree's impact on bone mineral density.

FTC’s PBM Investigation Could Lead to Unintended Consequences

August 9th 2022

Susan Lang, CEO and founder of XIL Health, talks about the shifting trends and pressures that have led to a misalignment between the PBMs, their clients and consumers.

CivicaScript Launches Generic Abiraterone

August 9th 2022

Abiraterone is used together with prednisone to treat patients with metastatic prostate cancer.